- alle zwei WochenErscheinungsrhythmus
- 46 mintypische Länge
- vor 4 Tagenletzte Folge
Folgenzu den neuesten
Jason Arnold - microbiome core facilities
Jason Arnold, Technical Director of the Microbiome Core Facility at UNC Chapel Hill, describes methods of improving the scientific rigor of microbiota research and his experiences as a snake breeder. The Bioinformatics CRO is a fully distri
Bettina Hein - managing chronic illness with AI
Bettina Hein, CEO and founder of juli, is a serial tech entrepreneur, using artificial intelligence to help people manage symptoms of chronic illness. The Bioinformatics CRO is a fully distributed contract research company that serves the c
Bharath Ramsundar - applications of AI
Bharath Ramsundar, founder and CEO of Deep Forest Sciences, described many applications of artificial intelligence in biotech, society, and the military. The Bioinformatics CRO is a fully distributed contract research company that serves th
Saroja Voruganti - nutrition and genetics
Saroja Voruganti, Associate Professor at UNC Chapel Hill, shares her passion for nutrition as she discusses the fields of nutrigenetics and nutrigenomics. The Bioinformatics CRO is a fully distributed contract research company that serves t
Jon Chee - equipment leasing for life sciences
Jon Chee, co-founder and CEO of Excedr, shares his experience founding a life sciences equipment leasing company before the latest biotech boom. The Bioinformatics CRO is a fully distributed contract research company that serves the computa
Ian Carroll - the intestinal microbiota
Ian Carroll, assistant professor of nutrition at the University of North Carolina, Chapel Hill, describes the relationship between the intestinal microbiota and eating disorders. The Bioinformatics CRO is a fully distributed contract resear
Mark Kotter - stem cell programming
Mark Kotter, co-founder and CEO of Bit Bio, discusses the uses of reprogrammed human cells in research and drug development. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs
Matthias Gromeier - viral cancer therapeutics
Matthias Gromeier, professor of neurosurgery at Duke University, describes how his breakthrough therapeutic combines poliovirus and rhinovirus to eliminate brain cancers. The Bioinformatics CRO is a fully distributed contract research compa
Carolyn Coyne - immunity in the placenta
Carolyn Coyne, professor of Molecular Genetics and Microbiology at Duke University, discusses how pathogens can subvert cellular barriers in the placenta and gut to cause disease. The Bioinformatics CRO is a fully distributed contract resea
Bryan Cullen - viral genetics
Bryan Cullen, director of Duke University's Center for Virology, describes how viruses use microRNAs, epigenetics, and epitranscriptomics to regulate their biology. The Bioinformatics CRO is a fully distributed contract research company tha
Micah Luftig - Epstein-Barr virus and cancer
Micah Luftig, associate professor and vice-chair of Molecular Genetics and Microbiology at Duke University, explains how Epstein-Barr virus can induce tumorigenesis and how is father inspired him to become a virologist. The Bioinformatics C
Jim Ray - treating Alzheimer's disease
Jim Ray, head of MD Anderson's Neurodegeneration Consortium, explains new perspectives in Alzheimer's disease research and shares his experience in biotech, pharma, and academia. The Bioinformatics CRO is a fully distributed contract resear
Fernando Martinez - anti-aging drug development
Fernando Martinez, senior scientist at Fountain Therapeutics, uses AI and phenotypic screening to discover drugs that reduce the signs of aging. The Bioinformatics CRO is a fully distributed contract research company that serves the computa
Jeremy Kamil - SARS-CoV-2 genetics with guest host Razib Khan
Jeremy Kamil, associate professor of microbiology at LSU Health Shreveport, discusses the genetics of SARS-CoV-2, variants, and vaccines with guest host Razib Khan. The Bioinformatics CRO is a fully distributed contract research company tha
Adam Robertson - broad-spectrum cancer therapeutics
Adam Robertson, CSO of Hemispherian, talks about developing cancer therapeutics in an Oslo-based startup. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic resear
Brett Abrahams - drug development and neurogenomics
Brett Abrahams, Executive VP of R&D at Magnolia Neurosciences, discusses his work on chemotherapy-induced peripheral neuropathy and other brain disorders. The Bioinformatics CRO is a fully distributed contract research company that serves t
Noor Siddiqui - preimplantation screening with polygenic risk scores
We spoke with Noor Siddiqui about how Orchid is using polygenic risk scores for common diseases for preimplantation screening. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology nee
Matthew Holt - astrocyte biologist
Matthew Holt, neuroscience professor at VIB-KU Leuven, explains the role of glial cells in neurodegenerative diseases and discusses boxing and motorbike racing. The Bioinformatics CRO is a fully distributed contract research company that se
Lucia Huang & Jimmy Qian - mental health tech
Lucia and Jimmy, co-founders of Osmind, discuss psychedelic therapies for mental illness, the future of the Bay Area, and public benefit corporations. The Bioinformatics CRO is a fully distributed contract research company that serves the c
Grant Belgard - remote work in biotech
Our regular host, Grant Belgard, founder of The Bioinformatics CRO, talks about his career working remotely and how he expects technology to change the biotech industry. The Bioinformatics CRO is a fully distributed contract research compan
Ambika Bumb - from nanotech to government service
We talk with Ambika Bumb, science and technology advisor to the department of state's crisis management and strategy team, about nanotechnology, the pandemic, and biotech start-ups. The Bioinformatics CRO is a fully distributed contract res
Lucas Steuber - mindreading with BCIs and AR
We talk with Lucas Steuber, clinical product and marketing director at Cognixion, about using a brain-computer interface and augmented reality to help people with speech disabilities communicate. The Bioinformatics CRO is a fully distribute
Trevor Martin - CRISPR diagnostics for COVID-19
We talk with Trevor Martin, co-founder and CEO of Mammoth Biosciences, about using CRISPR technology to detect SARS-CoV-2, his experience as a new CEO, and science education. The Bioinformatics CRO is a fully distributed contract research c
Dan Geschwind - precision medicine
Dan Geschwind, professor and associate vice chancellor at UCLA, shares his path to neuroscience, thoughts on precision medicine, and why one should use unbiased methods to prioritize hypotheses. The Bioinformatics CRO is a fully distributed
Deepti Gurdasani, Christina Pagel & Nisreen Alwan - why vaccines may not end the COVID pandemic
In our first panel discussion, three COVID experts share their thoughts on emerging variants of SARS-CoV-2 and the growing selective pressures for immune escape. The Bioinformatics CRO is a fully distributed contract research company that s
Delian Asparouhov - space manufacturing
Delian Asparouhov, co-founder of Varda Space Industries and principal at Founders Fund, talks about space manufacturing, economic bubbles, and tech investing. The Bioinformatics CRO is a fully distributed contract research company that serv
Vay Cao - Free the PhD, work beyond academia
We chat with Vay Cao, founder of Free the PhD, about her journey from neuroscience to an MSL-like role and how PhDs can leverage their experiences to get that first job outside academia. The Bioinformatics CRO is a fully distributed contrac
Mark DePristo - designing antibodies with machine learning
We talk with Mark DePristo, founder and CEO of BigHat Biosciences, about building better antibody therapeutics using machine learning, overcoming the fear of failure, and the pros and cons of working in academia, for large companies like Go
Shaan Gandhi - biotech venture capital
We talk with Shaan Gandhi, Director at Northpond Ventures, about the intersections of science, medicine, and business and how his training as an internist has colored his experience in venture capital. (Recorded on January 18, 2021) The Bio
Peter Joyce - founding a virtual biotech
We talk with Peter Joyce, co-founder and CEO of Grey Wolf Therapeutics, about novel cancer therapies, running a virtual biotech company, and encouraging a new generation of well-rounded scientists. (Recorded on December 16, 2020) The Bioinf
